fashion -WSS

fashion

author：explore 2025-09-07 11:15:40 - browse：28764

WASHINGTON — A White House task force created to work on drug shortage reforms has yet to contact the lawmakers who are writing legislation to stem shortages — and it’s not clear when the task force will recommend policies.

The White House formed a task force at the beginning of 2023 to deal with the issue of persistent drug shortages. Fifty-seven percent of hospital pharmacists said they are facing critical shortages of chemotherapy drugs in a new survey from the American Society of Health-System Pharmacists. Hospital pharmacists also reported significant shortages of steroids, hormonal drugs, and oral liquids such as amoxicillin and lidocaine.

Yet industry and patient representatives who have met with task force members said there has been no indication of when they will make recommendations that could spur federal agencies to act and steer the debate in Congress.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Senate committee scrutinizes Medicare Advantage brokers

knowledge

focus

WSS

STAT Summit: Michael J. Fox on progress in Parkinson's research

Many breast cancer patients receive more radiation than needed

Sweden knocks USA out of World Cup in penalty kicks

Doctors are clamoring for more clarity on Paxlovid prescribing

Election results set back Medicaid expansion plans

FDA gives detailed accounting of AI

hotspot

fashion

explore

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Election results set back Medicaid expansion plans

DIEP, the 'gold standard' of breast reconstruction, is under threat

'Brian's Song' at 50 still offers lessons about cancer for today

In Memoriam: Notable people who died in 2023

It was time to plan for my old age. If only I could stop crying

Virginia high school admissions case could be legal follow

Tuberculosis patients need more than just free medication

Alkermes shareholders re

FDA gives detailed accounting of AI

focus

With heat waves through August, officials warn of health risks

Studies point to risks of excluding people with obesity from drug trials

STAT Readout Newsletter: Today's biggest biotech updates

Pharmacists can make shortage drugs, but at what cost?

Medicare reduced heart disease by changing how it pays doctors

How CRISPR works, explained in two minutes

focus

knowledge

focus

leisure time